Signature Estate & Investment Advisors’s Roivant Sciences ROIV Stock Holding History

Signature Estate & Investment Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.99M	Buy	+197,419	New	+$5.83M	0.13%	77

Other funds holding ROIV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PDM

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Signature Estate & Investment Advisors's ROIV Position: Q2 2026 in Review

Signature Estate & Investment Advisors opened a new position in Roivant Sciences (ROIV) in Q2 2026: 197,419 shares worth $6.99M. The stake represents 0.13% of the portfolio and ranks #77 among its holdings.

220 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Signature Estate & Investment Advisors held 197,419 shares of Roivant Sciences worth $6.99M as of Q2 2026.
Roivant Sciences was a new Signature Estate & Investment Advisors position in Q2 2026.
Roivant Sciences made up 0.13% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #77 holding.
220 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.